Furthermore, colon cancer cells, namely, HT29, SW620, and SW837 when treated with dinaciclib showed decreased the expression levels for LGR5, ID1, and CD44v9 (Fig. 7B and Supplementary Fig. 7A). Here, LGR5 is linked to colonic neoplasm.